• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.13% Nasdaq Up0.14%

    Protalix BioTherapeutics, Inc. (PLX)

    0.78 Down 0.01(0.89%) May 26, 4:00PM EDT
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.5
    Mean Recommendation (last week):1.5

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:2.63
    Median Target:2.63
    High Target:3.50
    Low Target:1.75
    No. of Brokers:2

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Apr 4, 2016Rodman & RenshawInitiated Buy
    Apr 23, 2015JefferiesUpgradeHoldBuy
    Jan 24, 2014R. F. LaffertyInitiated Buy
    May 2, 2012Canaccord GenuityDowngradeBuyHold
    Apr 30, 2012AurigaDowngradeBuyHold
    Mar 17, 2011WBB SecuritiesDowngradeStrong BuyBuy
    Sep 2, 2009HapoalimInitiated Outperform
    Mar 11, 2008UBSInitiated Buy
    Nov 20, 2007CIBC Wrld MktsInitiated Sector Outperform
    May 22, 2000Salomon Smth BrnyUpgradeOutperformBuy

    More Upgrades & Downgrades for PLX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1111

    Data provided by Thomson/First Call

    Currency in USD.